1 |
CH505 - the Env that was obtained from patient CH505 who developed neutralization breadth during follow-up from acute HIV-1 infection. This person was the first CHAVI 17 participant who was studied for ant [..]
|
<< Broadly neutralizing antibodies | CHAVI 17 >> |